RU2016144076A - Сильнодействующие и селективные ингибиторы вируса гепатита с - Google Patents
Сильнодействующие и селективные ингибиторы вируса гепатита с Download PDFInfo
- Publication number
- RU2016144076A RU2016144076A RU2016144076A RU2016144076A RU2016144076A RU 2016144076 A RU2016144076 A RU 2016144076A RU 2016144076 A RU2016144076 A RU 2016144076A RU 2016144076 A RU2016144076 A RU 2016144076A RU 2016144076 A RU2016144076 A RU 2016144076A
- Authority
- RU
- Russia
- Prior art keywords
- alkyl
- aryl
- hcv
- compound according
- paragraphs
- Prior art date
Links
- 241000711549 Hepacivirus C Species 0.000 title claims 3
- 239000003112 inhibitor Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims 20
- 125000000217 alkyl group Chemical group 0.000 claims 9
- 239000003814 drug Substances 0.000 claims 7
- 208000015181 infectious disease Diseases 0.000 claims 6
- 125000001424 substituent group Chemical group 0.000 claims 6
- 125000003118 aryl group Chemical group 0.000 claims 5
- 238000000034 method Methods 0.000 claims 5
- 239000003795 chemical substances by application Substances 0.000 claims 4
- 239000000203 mixture Substances 0.000 claims 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 4
- 238000011282 treatment Methods 0.000 claims 4
- 125000002877 alkyl aryl group Chemical group 0.000 claims 3
- 229910052799 carbon Inorganic materials 0.000 claims 3
- 239000003937 drug carrier Substances 0.000 claims 3
- 229910052739 hydrogen Inorganic materials 0.000 claims 3
- 229940002612 prodrug Drugs 0.000 claims 3
- 239000000651 prodrug Substances 0.000 claims 3
- 238000011321 prophylaxis Methods 0.000 claims 3
- 150000003839 salts Chemical class 0.000 claims 3
- 125000003342 alkenyl group Chemical group 0.000 claims 2
- 125000004183 alkoxy alkyl group Chemical group 0.000 claims 2
- -1 alkyl amide Chemical class 0.000 claims 2
- 125000000304 alkynyl group Chemical group 0.000 claims 2
- 230000004071 biological effect Effects 0.000 claims 2
- 229910052801 chlorine Inorganic materials 0.000 claims 2
- 125000000753 cycloalkyl group Chemical group 0.000 claims 2
- 125000001188 haloalkyl group Chemical group 0.000 claims 2
- 125000001072 heteroaryl group Chemical group 0.000 claims 2
- 125000000623 heterocyclic group Chemical group 0.000 claims 2
- 230000002265 prevention Effects 0.000 claims 2
- 125000004890 (C1-C6) alkylamino group Chemical group 0.000 claims 1
- 125000003545 alkoxy group Chemical group 0.000 claims 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims 1
- 125000005189 alkyl hydroxy group Chemical group 0.000 claims 1
- 150000001356 alkyl thiols Chemical class 0.000 claims 1
- 125000004103 aminoalkyl group Chemical group 0.000 claims 1
- 125000005098 aryl alkoxy carbonyl group Chemical group 0.000 claims 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 1
- 229910052794 bromium Inorganic materials 0.000 claims 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 229910052731 fluorine Inorganic materials 0.000 claims 1
- 229910052736 halogen Inorganic materials 0.000 claims 1
- 150000002367 halogens Chemical class 0.000 claims 1
- 125000005842 heteroatom Chemical group 0.000 claims 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims 1
- 229910052740 iodine Inorganic materials 0.000 claims 1
- 229910052757 nitrogen Inorganic materials 0.000 claims 1
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 1
- 229910052760 oxygen Inorganic materials 0.000 claims 1
- 229910052717 sulfur Inorganic materials 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461980016P | 2014-04-15 | 2014-04-15 | |
| US61/980,016 | 2014-04-15 | ||
| PCT/US2015/025903 WO2015160907A2 (en) | 2014-04-15 | 2015-04-15 | Potent and selective inhibitors of hepatitis c virus |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2016144076A true RU2016144076A (ru) | 2018-05-16 |
Family
ID=54324704
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2016144076A RU2016144076A (ru) | 2014-04-15 | 2015-04-15 | Сильнодействующие и селективные ингибиторы вируса гепатита с |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US9926295B2 (OSRAM) |
| EP (1) | EP3131892A4 (OSRAM) |
| JP (1) | JP2017513852A (OSRAM) |
| KR (1) | KR20170002407A (OSRAM) |
| CN (1) | CN106661004A (OSRAM) |
| AU (1) | AU2015247706A1 (OSRAM) |
| BR (1) | BR112016023833A2 (OSRAM) |
| CA (1) | CA2945514A1 (OSRAM) |
| IL (1) | IL248318A0 (OSRAM) |
| MX (1) | MX2016013434A (OSRAM) |
| PH (1) | PH12016502039A1 (OSRAM) |
| RU (1) | RU2016144076A (OSRAM) |
| SG (1) | SG11201608587QA (OSRAM) |
| WO (1) | WO2015160907A2 (OSRAM) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9717712B2 (en) | 2013-07-02 | 2017-08-01 | Bristol-Myers Squibb Company | Combinations comprising tricyclohexadecahexaene derivatives for use in the treatment of hepatitis C virus |
| US9775831B2 (en) | 2013-07-17 | 2017-10-03 | Bristol-Myers Squibb Company | Combinations comprising biphenyl derivatives for use in the treatment of HCV |
| WO2015184644A1 (zh) * | 2014-06-06 | 2015-12-10 | 爱博新药研发(上海)有限公司 | 抑制丙肝病毒的化合物、药物组合物及其应用 |
| US10617675B2 (en) | 2015-08-06 | 2020-04-14 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| TWI833753B (zh) * | 2018-05-09 | 2024-03-01 | 美商共結晶製藥公司 | 用於治療hcv之組合療法 |
| CN109456375B (zh) * | 2018-12-11 | 2019-10-22 | 枣庄学院 | 一种抑制丙肝病毒的含单糖基杂环类化合物及制备方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0822323A2 (pt) * | 2008-02-13 | 2015-06-16 | Bristol Myers Squibb Co | Imidazolil bifenil imidazóis como inibidores do vírus da hepatite c |
| CN102395590A (zh) * | 2009-02-06 | 2012-03-28 | Rfs制药公司 | 用于治疗癌症和病毒感染的嘌呤核苷单磷酸酯前药 |
| US8377980B2 (en) * | 2009-12-16 | 2013-02-19 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| EP2616461A4 (en) * | 2010-08-26 | 2014-03-26 | Rfs Pharma Llc | POTENTIVE AND SELECTIVE INHIBITORS OF HEPATITIS C VIRUS |
| WO2012048421A1 (en) * | 2010-10-14 | 2012-04-19 | Boehringer Ingelheim International Gmbh | Hepatitis c inhibitor compounds |
| BR112013010836A2 (pt) * | 2010-11-01 | 2019-09-24 | Genoscience Pharma | inibidores específicos de ns3 protease de hcv |
-
2015
- 2015-04-15 EP EP15779578.2A patent/EP3131892A4/en not_active Withdrawn
- 2015-04-15 BR BR112016023833A patent/BR112016023833A2/pt active Search and Examination
- 2015-04-15 CN CN201580032237.0A patent/CN106661004A/zh active Pending
- 2015-04-15 US US15/303,277 patent/US9926295B2/en active Active
- 2015-04-15 SG SG11201608587QA patent/SG11201608587QA/en unknown
- 2015-04-15 AU AU2015247706A patent/AU2015247706A1/en not_active Abandoned
- 2015-04-15 JP JP2016562874A patent/JP2017513852A/ja active Pending
- 2015-04-15 CA CA2945514A patent/CA2945514A1/en not_active Abandoned
- 2015-04-15 WO PCT/US2015/025903 patent/WO2015160907A2/en not_active Ceased
- 2015-04-15 KR KR1020167030815A patent/KR20170002407A/ko not_active Withdrawn
- 2015-04-15 RU RU2016144076A patent/RU2016144076A/ru unknown
- 2015-04-15 MX MX2016013434A patent/MX2016013434A/es unknown
-
2016
- 2016-10-12 PH PH12016502039A patent/PH12016502039A1/en unknown
- 2016-10-13 IL IL248318A patent/IL248318A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX2016013434A (es) | 2017-03-03 |
| PH12016502039A1 (en) | 2017-01-09 |
| CN106661004A (zh) | 2017-05-10 |
| EP3131892A4 (en) | 2017-09-20 |
| KR20170002407A (ko) | 2017-01-06 |
| US9926295B2 (en) | 2018-03-27 |
| CA2945514A1 (en) | 2015-10-22 |
| WO2015160907A2 (en) | 2015-10-22 |
| US20170029407A1 (en) | 2017-02-02 |
| SG11201608587QA (en) | 2016-11-29 |
| AU2015247706A1 (en) | 2016-10-27 |
| EP3131892A2 (en) | 2017-02-22 |
| IL248318A0 (en) | 2016-11-30 |
| WO2015160907A3 (en) | 2016-12-01 |
| BR112016023833A2 (pt) | 2017-10-10 |
| JP2017513852A (ja) | 2017-06-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2016144076A (ru) | Сильнодействующие и селективные ингибиторы вируса гепатита с | |
| SI3024819T1 (en) | Glyoxamide-substituted pyrrolamide derivatives and their use as medicines for the treatment of hepatitis B | |
| JP2019507774A5 (OSRAM) | ||
| EA201201031A1 (ru) | Ингибиторы вируса гепатита с | |
| JP2017523169A5 (OSRAM) | ||
| JP2016518434A5 (OSRAM) | ||
| JP2017537949A5 (OSRAM) | ||
| JP2016518437A5 (OSRAM) | ||
| RU2012146986A (ru) | Цефемовые соединения, содержащие катехольную группу | |
| BR112014019478A2 (pt) | composto ou um sal farmacologicamente aceitável do mesmo, composição farmacêutica, uso de um composto ou de um sal farmacologicamente aceitável do mesmo, formulação inibidor do canal de sódio, métodos para tratamento e/ou prevenção de dor e de uma doença. | |
| JP2017508789A5 (OSRAM) | ||
| RU2014113539A (ru) | Тетрациклические гетероциклические соединения и способы их применения для лечения вирусных заболеваний | |
| JP2015500843A5 (OSRAM) | ||
| JP2017505314A5 (OSRAM) | ||
| JP2014511892A5 (OSRAM) | ||
| RU2012117829A (ru) | Фосфорамидатные производные нуклеозидов | |
| JP2019500387A5 (OSRAM) | ||
| RU2013108348A (ru) | Конденсированные гетероарилы и их применение | |
| JP2016503797A5 (OSRAM) | ||
| RU2008139195A (ru) | Замещенные арилсульфанамиды как противовирусные средства | |
| RU2014107484A (ru) | ПРИМЕНЕНИЕ СОЕДИНЕНИЙ 2,3-ДИГИДРОИМИДАЗО[1,2-с]ПИРИМИДИН-5(1H)-ОНА В КАЧЕСТВЕ ИНГИБИТОРОВ LP-PLA2 | |
| RU2018112312A (ru) | Пиридинондикарбоксамиды для применения в качестве ингибиторов бромодомена | |
| SI3166925T1 (en) | Isoindoline derivatives for use in treating a viral infection | |
| RU2015150120A (ru) | Соединение дикарбоновой кислоты | |
| RU2017103656A (ru) | Производные изоиндолинона, полезные в качестве противовирусных средств |